Woodland International Research Group Inc. — Little Rock, Arkansas

Woodland International Research Group Inc. is a clinical research site located in Little Rock, Arkansas, United States 72211.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Woodland International Research Group Inc. has participated in 3 clinical trials.

Therapeutic areas: Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, Schizophrenia.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Woodland International Research Group Inc.?

Woodland International Research Group Inc. has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Woodland International Research Group Inc. conducted?

Woodland International Research Group Inc. has 3 clinical trials on record. Their work covers Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, Schizophrenia.

Is Woodland International Research Group Inc. accredited by Crixeo Health?

Woodland International Research Group Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Woodland International Research Group Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.